Search
for
Sort by
Research 901–930 of 1000+
- Enoxaparin-induced alopecia in patients with cerebral venous thrombosis
- Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model
- Identification of Drug-Disease Associations Using Information of Molecular Structures and Clinical Symptoms via Deep Convolutional Neural Network
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
- Mechanisms of proton inhibition and sensitization of the cation channel TRPV3
- Lithium: one drug, five complications
- Semifluorinated Alkanes as New Drug Carriers—An Overview of Potential Medical and Clinical Applications
- Carvone Decreases Melanin Content by Inhibiting Melanoma Cell Proliferation via the Cyclic Adenosine Monophosphate (cAMP) Pathway
- Allopregnanolone is required for prepulse inhibition deficits induced by D1 dopamine receptor activation
- Bendamustine: an Old Drug in the New Era for Patients with Non-Hodgkin Lymphomas and Chronic Lymphocytic Leukemia
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption
- Protein degradation: expanding the toolbox to restrain cancer drug resistance
- In Vitro and In Vivo Assessment of Metabolic Drug Interaction Potential of Dutasteride with Ketoconazole
- Alcohol extract from Vernonia anthelmintica willd (L.) seed counteracts stress-induced murine hair follicle growth inhibition
- Finasteride, a 5alpha-reductase inhibitor, potentiates antinociceptive effects of morphine, prevents the development of morphine tolerance and attenuates abstinence behavior in the rat
- The Benefits of Dual Inhibition of 5α Reductase
- Self-Emulsifying Drug Delivery Systems (SEDDS): Measuring Energy Dynamics to Determine Thermodynamic and Kinetic Stability
- Development of a Liquid Chromatography/Mass Spectrometry-Based Inhibition Assay for the Screening of Steroid 5-α Reductase in Human and Fish Cell Lines
- Data-driven strategies for drug repurposing: insights, recommendations, and case studies
- A Phytochemical and Pharmacological Review on <i>Cynomorium songaricum</i> as Functional and Medicinal Food
- Advancements in Drug Repurposing: Examples in Psychiatric Medications
- Combining rapid degrading microneedles with Slow-Released drug delivery system for the treatment of alopecia areata
- Use of the drug Wolvit® (biotin 5 mg) in treatment of defuse telogenous alopecia
- Hair loss in the era of CGRP inhibition: emerging evidence, mechanisms, and clinical implications
- Chemotherapy and the Skin: Understanding Dermatologic Side Effects
- Teicoplanin alleviates androgenetic alopecia through inhibition of androgen receptor expression and enhancing dermal papilla cell proliferation